T1	eligibility 588 643	Older women with invasive, non-metastatic breast cancer
T2	age 242 252	â‰¥ 65 years
T3	intervention-participants 647 650	150
T4	control-participants 656 659	530
T5	outcome 1013 1035	Anthracycline regimens
T6	outcome 1205 1228	global QoL at 24 months
T7	outcome 1429 1462	improvement in emotional function
T8	outcome 1541 1587	reductions in therapy side effects and fatigue
T9	iv-cont-mean 1170 1181	13.7 points
T10	cv-cont-mean 1316 1326	7.0 points
T11	intervention 126 147	standard chemotherapy
T12	control 186 205	observational study
T13	outcome 1674 1690	QoL trajectories
